about
Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials.Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.Models in the Research Process of Psoriasis.A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.Contextual control of skin immunity and inflammation by Corynebacterium.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.Shifting the Focus: The Primary Role of IL-23 in Psoriasis and other Inflammatory Disorders.IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management.Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
P2860
Q38557350-34450E2E-C6CD-4C59-806C-9F4ABB45F3F5Q45977850-40BE5535-EC15-49C3-91A9-970E6F4251E8Q47181496-9E6131EE-0A98-4D72-82AA-CBA8A61357B6Q47657450-DFB3EE12-2AF4-4DC0-9FFD-7A2F27ED2EC9Q48139471-958A736C-F911-4B68-B8F8-C78D189C57F3Q49210038-2D61C8E3-AB4B-47A2-94AD-5216850240C2Q50041283-C32A18A3-F744-4EF3-8BA5-B58391E47642Q52802857-D919427A-E54E-48F4-899D-191BDBE68D16Q53123754-B9A7A516-C64E-4861-BBC6-4DE7E1D7FE02Q55152453-F8345A89-BCC3-4B9A-B62B-F6E293E02FA4Q58694359-3A711F9F-3D52-4629-80E3-B0856A514E5F
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The role of IL 23 in the treatment of psoriasis.
@en
type
label
The role of IL 23 in the treatment of psoriasis.
@en
prefLabel
The role of IL 23 in the treatment of psoriasis.
@en
P2860
P1476
The role of IL 23 in the treatment of psoriasis.
@en
P2093
Lluís Puig
P2860
P304
P356
10.1080/1744666X.2017.1292137
P577
2017-02-06T00:00:00Z